StrongBox Wealth’s Travere Therapeutics TVTX Stock Holding History

StrongBox Wealth’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$118	Buy	+2	New	+$122	﹤0.01%	340

Other funds holding TVTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

StrongBox Wealth's TVTX Position: Q3 2026 in Review

StrongBox Wealth opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 2 shares worth $118. The stake represents ﹤0.01% of the portfolio and ranks #340 among its holdings.

100 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

StrongBox Wealth held 2 shares of Travere Therapeutics worth $118 as of Q3 2026.
Travere Therapeutics was a new StrongBox Wealth position in Q3 2026.
Travere Therapeutics made up ﹤0.01% of StrongBox Wealth's portfolio in Q3 2026, its #340 holding.
100 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on StrongBox Wealth's 13F filing for Q3 2026, filed 2 Nov 2026.